Literature DB >> 30416846

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.

Shenghang Wang1,2, Jie Luo1,2, Zhihao Zhang1,2, Dandan Dong1,2, Ying Shen1,2, Yanwen Fang3, Lijiang Hu3, Mengyu Liu3, Chengfu Dai4, Songlin Peng4, Zhicai Fang3, Peng Shang5,2.   

Abstract

Ferroptosis is an iron depend cell death which caused by lipid peroxidation. Abnormal iron metabolism and high intracellular iron content are the characteristics of most cancer cells. Iron is a promoter of cell growth and proliferation. However, iron also could take part in Fenton reaction to produce reactive oxygen species (ROS). The intercellular ROS could induce lipid peroxidation, which is necessary for ferroptosis. Iron metabolism mainly includes three parts: iron uptake, storage and efflux. Therefore, iron metabolism-related genes could regulate intercellular iron content and status, which can be involved ferroptosis. In recent years, the application of nanoparticles in cancer therapy research has become more and more extensive. The iron-based nanoparticles (iron-based NPs) can release ferrous (Fe2+) or ferric (Fe3+) in acidic lysosomes and inducing ferroptosis. Magnetic field is widely used in the targeted concentration of iron-based NPs related disease therapy. Furthermore, multiple studies showed that magnetic fields can inhibit cancer cell proliferation by promoting intracellular ROS production. Herein, we focus on the relationship of between ferroptosis and iron metabolism in cancer cells, the application of nanoparticles and magnetic field in inducing ferroptosis of cancer cells, and trying to provide new ideas for cancer treatment research.

Entities:  

Keywords:  Iron metabolism; cancer therapy; ferroptosis; iron-based nanoparticles; magnetic field

Year:  2018        PMID: 30416846      PMCID: PMC6220147     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  79 in total

1.  Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool.

Authors:  Or Kakhlon; Yosef Gruenbaum; Z Ioav Cabantchik
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

2.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

3.  Cit/CuS@Fe3O4-based and enzyme-responsive magnetic nanoparticles for tumor chemotherapy, photothermal, and photodynamic therapy.

Authors:  Xiali Zhu; Heqing Huang; Yingjie Zhang; Huijuan Zhang; Lin Hou; Zhenzhong Zhang
Journal:  J Biomater Appl       Date:  2016-10-26       Impact factor: 2.646

Review 4.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

5.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

Review 6.  Microenvironmental and cellular consequences of altered blood flow in tumours.

Authors:  N Raghunand; R A Gatenby; R J Gillies
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

7.  Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.

Authors:  Weijun Ou; Rohit S Mulik; Arnida Anwar; Jeffrey G McDonald; Xiaoshun He; Ian R Corbin
Journal:  Free Radic Biol Med       Date:  2017-09-08       Impact factor: 7.376

8.  Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.

Authors:  Lei Zhang; Faming Gong; Fang Zhang; Jing Ma; Peidong Zhang; Jun Shen
Journal:  Int J Nanomedicine       Date:  2013-04-17

9.  Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy.

Authors:  Yu-Lin Su; Jen-Hung Fang; Chia-Ying Liao; Chein-Ting Lin; Yun-Ting Li; Shang-Hsiu Hu
Journal:  Theranostics       Date:  2015-08-09       Impact factor: 11.556

10.  Disordered hepcidin-ferroportin signaling promotes breast cancer growth.

Authors:  Shuping Zhang; Yue Chen; Wenli Guo; Lin Yuan; Daoqiang Zhang; Yong Xu; Elizabeta Nemeth; Tomas Ganz; Sijin Liu
Journal:  Cell Signal       Date:  2014-08-03       Impact factor: 4.315

View more
  31 in total

Review 1.  Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Authors:  Shana J Cameron; Jessica Sheng; Farah Hosseinian; William G Willmore
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

Review 2.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Authors:  Fu Peng; Minru Liao; Rui Qin; Shiou Zhu; Cheng Peng; Leilei Fu; Yi Chen; Bo Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 3.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.

Authors:  Weitong Gao; Xueying Wang; Yang Zhou; Xueqian Wang; Yan Yu
Journal:  Signal Transduct Target Ther       Date:  2022-06-20

4.  Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines.

Authors:  Roberto Fernández-Acosta; Claudia Iriarte-Mesa; Daniel Alvarez-Alminaque; Behrouz Hassannia; Bartosz Wiernicki; Alicia M Díaz-García; Peter Vandenabeele; Tom Vanden Berghe; Gilberto L Pardo Andreu
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

5.  Ginsenoside Rh4 Inhibits Colorectal Cancer Cell Proliferation by Inducing Ferroptosis via Autophagy Activation.

Authors:  Yingchao Wu; Dajin Pi; Yiliu Chen; Qian Zuo; Shuyao Zhou; Mingzi Ouyang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-29       Impact factor: 2.650

Review 6.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

Review 7.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

8.  Ferri-Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells.

Authors:  Marina Guedes Fonseca de Souza; Fabrícia Nunes de Jesus Guedes; Marli Luiza Tebaldi; Éverton do Nascimento Alencar; Lucas Amaral-Machado; Eryvaldo Sócrates Tabosa do Egito; André Luis Branco de Barros; Daniel Crístian Ferreira Soares
Journal:  Pharmaceutics       Date:  2021-05-13       Impact factor: 6.321

9.  Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.

Authors:  Jie Yao; Xiao Chen; Xiao Liu; Rui Li; Xijia Zhou; Yiqing Qu
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

Review 10.  Emerging mechanisms and targeted therapy of ferroptosis in cancer.

Authors:  Haiyan Wang; Yan Cheng; Chao Mao; Shuang Liu; Desheng Xiao; Jun Huang; Yongguang Tao
Journal:  Mol Ther       Date:  2021-03-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.